Acute Myeloid Leukemia Resource Center
Coverage from the 61st Annual ASH Meeting & Exposition: Focus on Acute Myeloid Leukemia

The 61st ASH Annual Meeting and Exposition will be held in Orlando, Fla., Dec. 7-10, 2019. Attendees will have access to thousands of scientific abstracts highlighting cutting-edge research in hematology. This conference is an opportunity to enhance your practice through educational programs while networking with leaders in the field. Check out highlights from the upcoming conferences to help you make the most of your time at ASH.

ASH 2019 Coverage:

Positive Data of APR-246 & Azacitidine in Patients with TP53 MDS & AML

Lead investigators from the U.S. and French phase Ib/II clinical trials of APR-246 and azacitidine (AZA) in patients with TP53-mutant myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), presented positive data at the 2019 ASH Annual Meeting. 

Read More

Examining OPB-111077 with Decitabine & Venetoclax for Acute Myeloid Leukemia

Researchers found that the combination of OPB-111077 and venetoclax in acute myeloid leukemia cells caused decreased proliferation and increased apoptosis rates to a greater degree than exposure to single agent OPB-111077 or venetoclax.

Read More

Primary Induction Failure & Early Relapsed Acute Myeloid Leukemia

Updated results from a phase I/II dose-expansion study of flotetuzumab, an investigational, bispecific CD123 x CD3 DART molecule in patients with primary induction failure and early relapsed acute myeloid leukemia were presented in an oral session at the 2019 ASH Annual Meeting.

Read More

Implications for CD117 Expression Levels in Pediatric & Young Adults With AML

There has been considerable interest recently in the expression of cell surface proteins in acute myeloid leukemia (AML), primarily as a result of their potential for being targeted therapeutically, as well as their prognostic implications in patient disease. In AML, one particular surface-bound protein of interest is the receptor tyrosine kinase CD117, also referred to as c-KIT. 

Read More